Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B

Vincent, Benjamin Matteson, Lancaster, Alex Kelvin, Scherz-Shouval, Ruth, Whitesell, Luke, Lindquist, Susan·2013·PLoS Biology

Cited by (325)

Items 101–200 of 325

  1. Finding the needle in a haystack: Mapping antifungal drug resistance in fungal pathogen by genomic approaches
    Dominique Sanglard · 2019 · PLoS Pathogens
  2. Plasma Membrane Proteolipid 3 Protein Modulates Amphotericin B Resistance throughSphingolipid Biosynthetic Pathway
    Vinay Kumar Bari, Sushma Sharma, Md. Alfatah, Alok Kumar Mondal, Kaliannan Ganesan · 2015 · Scientific Reports
  3. Gênero Candida - Fatores de virulência, Epidemiologia, Candidíase e Mecanismos de resistência
    Wilma Raianny Vieira da Rocha, Luanne Eugênia Nunes, Marina Luizy da Rocha Neves, Eulália Azevedo Ximenes, Mônica Camelo Pessoa de Azevedo Albuquerque · 2021 · Research Society and Development
  4. Candida glabrata: A powerhouse of resistance
    Seána Duggan, Jane Usher · 2023 · PLoS Pathogens
  5. Thermoreversible Gel-Loaded Amphotericin B for the Treatment of Dermal and Vaginal Candidiasis
    Lilian Sosa, Ana Cristina Calpena, Marcelle Silva-Abreu, Lupe Carolina Espinoza, María Rincón, Nuria Bozal-de Febrer, Òscar Domènech, Maria Jose Rodríguez-Lagunas, Beatriz Clares · 2019 · Pharmaceutics
  6. Chemical diversity and mode of action of natural products targeting lipids in the eukaryotic cell membrane
    Shinichi Nishimura, Nobuaki Matsumori · 2020 · Natural Product Reports
  7. Comparative Genomics of Aspergillus flavus S and L Morphotypes Yield Insights into Niche Adaptation
    Mana Ohkura, Peter J. Cotty, Marc J. Orbach · 2018 · G3 Genes Genomes Genetics
  8. Advances in fungal chemical genomics for the discovery of new antifungal agents
    Alice Xue, Nicole Robbins, Leah E. Cowen · 2020 · Annals of the New York Academy of Sciences
  9. Dissimilar Fitness Associated with Resistance to Fluoroquinolones Influences Clonal Dynamics of Various Multiresistant Bacteria
    M. Füzi · 2016 · Frontiers in Microbiology
  10. Enhanced in vitro antimicrobial activity of amphotericin B with berberine against dual‐species biofilms of Candida albicans and Staphylococcus aureus
    Shanjun Gao, Shuzhen Zhang, Shuzhen Zhang · 2020 · Journal of Applied Microbiology
  11. How urgent is the need for new antifungals?
    Adam G. Stewart, David L. Paterson · 2021 · Expert Opinion on Pharmacotherapy
  12. Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts
    Aimilia A. Stavrou, Antonio Pérez Hansen, Michaela Lackner, Cornelia Lass‐Flörl, Teun Boekhout · 2020 · Medical Mycology
  13. Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies
    Emily M. Stevenson, William H. Gaze, Neil A. R. Gow, Alwyn J. Hart, Wiebke Schmidt, Jane Usher, Adilia Warris, Helen Wilkinson, Aimee Kaye Murray · 2022 · Frontiers in Fungal Biology
  14. Recent advances in antifungal drug discovery based on polyene macrolide antibiotics
    Olga A. Omelchuk, Anna N. Tevyashova, Andrey Egorovich Shchekotikhin · 2018 · Russian Chemical Reviews
  15. Collateral sensitivity: An evolutionary trade‐off between antibiotic resistance mechanisms, attractive for dealing with drug‐resistance crisis
    Mina Yekani, Robab Azargun, Simin Sharifi, Edris Nabizadeh, Javid Sadri Nahand, Navideh Karimi Ansari, Mohammad Yousef Memar, József Sóki · 2023 · Health Science Reports
  16. Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance
    Peter T. Harrison, Paul H. Huang · 2018 · Essays in Biochemistry
  17. Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris
    Hans Carolus, Dimitrios Sofras, Giorgio Boccarella, Stef Jacobs, Vladislav V. Biriukov, Louise Goossens, Alicia Chen, Ina Vantyghem, Tibo Verbeeck, Siebe Pierson et al. · 2024 · Nature Microbiology
  18. Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungals
    Cecilia Gutierrez-Perez, Robert A. Cramer · 2025 · npj Antimicrobials and Resistance
  19. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinical Candida albicans and non-albicans isolates
    Amira M. El-Ganiny, Hend A. Kamel, Nehal E. Yossef, Basem Mansour, Ahmed Mohamed El-Baz · 2022 · Saudi Pharmaceutical Journal
  20. Reversing resistance: different routes and common themes across pathogens
    Richard C. Allen, Jan Engelstädter, Sebastian Bonhoeffer, Bruce Alan McDonald, Alex R. Hall · 2017 · Proceedings of the Royal Society B Biological Sciences
  21. Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species
    Ridhima Wadhwa, Parijat Pandey, Gaurav Gupta, Taru Aggarwal, Nitesh Kumar, Meenu Mehta, Saurabh Satija, Monica Gulati, Jyotsana Madan, Harish Dureja et al. · 2019 · Current Topics in Medicinal Chemistry
  22. Antifungal activity of boric acid, triclosan and zinc oxide against different clinically relevant Candida species
    Marly Alejandra Gavilanes‐Martínez, Alejandra Coral‐Garzón, Diego Hernando Caceres, Ana Maria Garcı́a · 2021 · Mycoses
  23. The Hydrophobin Gene Family Confers a Fitness Trade-off between Spore Dispersal and Host Colonization in Penicillium expansum
    Dianiris Luciano‐Rosario, Justin L. Eagan, Niraj Aryal, Eddie G. Dominguez, Christina M. Hull, Nancy P. Keller · 2022 · mBio
  24. Endogenous nitric oxide accumulation is involved in the antifungal activity of Shikonin against Candida albicans
    Zebin Liao, Yu Yan, Huaihuai Dong, Zhenyu Zhu, Yuanying Jiang, Yingying Cao · 2016 · Emerging Microbes & Infections
  25. Trends in Pediatric Candidemia: Epidemiology, Anti-Fungal Susceptibility, and Patient Characteristics in a Children’s Hospital
    Anabel Piqueras, Lakshmi Ganapathi, Jane F. Carpenter, Thomas T. Rubio, Thomas J. Sandora, Kelly B. Flett, Julia R. Köhler · 2021 · Journal of Fungi
  26. Antifungal Drugs: The Current Armamentarium and Development of New Agents
    Nicole Robbins, Gerard D. Wright, Leah E. Cowen · 2017 · ASM Press eBooks
  27. Semisynthetic Amides of Amphotericin B and Nystatin A1: A Comparative Study of In Vitro Activity/Toxicity Ratio in Relation to Selectivity to Ergosterol Membranes
    Anna N. Tevyashova, Svetlana S. Efimova, Alexander I. Alexandrov, Olga A. Omelchuk, Eslam S. M. O. Ghazy, Елена Николаевна Бычкова, George V. Zatonsky, Natalia E. Grammatikova, Lyubov G. Dezhenkova, Svetlana E. Solovieva et al. · 2023 · Antibiotics
  28. The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
    Kylie J. Boyce · 2023 · Microorganisms
  29. Prevalence and antifungal drug resistance of nosocomial Candida species isolated from two university hospitals in Egypt
    Amira M. El-Ganiny, Nehal E. Yossef, Hend A. Kamel · 2021 · Current Medical Mycology
  30. Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer
    Xiaolong Tang, Jingjing Dai, Jun Xie, Yongqiang Zhu, Ming Zhu, Zhi Wang, Chunmei Xie, Aixia Yao, Tingting Liu, Xiaoyu Wang et al. · 2015 · Nanoscale Research Letters
  31. Identification of Inhibitors of Fungal Fatty Acid Biosynthesis
    Christian A. DeJarnette, Chris J. Meyer, Alexander R. Jenner, Arielle Butts, Tracy L. Peters, Martin N. Cheramie, Gregory A. Phelps, Nicole A. Vita, Victoria C. Loudon, Richard E. Lee Jr. et al. · 2021 · ACS Infectious Diseases
  32. Natural Substances as Valuable Alternative for Improving Conventional Antifungal Chemotherapy: Lights and Shadows
    Juan Carlos Argüelles, Ruth Sánchez-Fresneda, Alejandra Argüelles, Francisco Solano · 2024 · Journal of Fungi
  33. Role of Catalase Overproduction in Drug Resistance and Virulence in Candida Albicans
    Elvira Román, Daniel Prieto, Roberto Julián Martín, Inês Correia, Ana Cecilia Mesa Arango, Rebeca Alonso‐Monge, Óscar Zaragoza, Jesús Plá · 2016 · Future Microbiology
  34. Advances in Candida albicans
    Xinhui Wang · 2021 · Infectious diseases
  35. The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
    Cengiz Zobi, Öztekin Algül · 2025 · Chemical Biology & Drug Design
  36. Exploration of the Substrate Promiscuity of Biosynthetic Tailoring Enzymes as a New Source of Structural Diversity for Polyene Macrolide Antifungals
    Javier Santos‐Aberturas, Jennifer Engel, Jonathan Dickerhoff, Mark Dörr, Florian Rudroff, Klaus Weisz, Uwe T. Bornscheuer · 2014 · ChemCatChem
  37. Candida auris: The Canary in the Mine of Antifungal Drug Resistance
    Marhiah C. Montoya, Scott Moye-Rowley, Damian J. Krysan · 2019 · ACS Infectious Diseases
  38. Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites
    Andrew W. Pountain, Michael Peter Barrett · 2019 · Wellcome Open Research
  39. Systemic Antifungal Therapy for Invasive Pulmonary Infections
    Ronen Ben‐Ami · 2023 · Journal of Fungi
  40. Antifungal resistance, combinations and pipeline: oh my!
    Kayla R. Stover, Brandon K. Hawkins, Jacob M. Keck, Katie E. Barber, David A. Cretella · 2023 · Drugs in Context
  41. Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi
    Xuefei Chen, H. Diessel Duan, Michael J. Hoy, Kalinka K. Koteva, Michaela Spitzer, Allison K. Guitor, Emily Puumala, Aline Fiebig‐Comyn, Guanggan Hu, Bonnie Yiu et al. · 2025 · Cell
  42. Transcriptome and network analyses in Saccharomyces cerevisiae reveal that amphotericin B and lactoferrin synergy disrupt metal homeostasis and stress response
    Chi Nam Ignatius Pang, Yu-Wen Lai, Leona T. Campbell, Sharon C.-A. Chen, Dee A. Carter, Marc Ronald Wilkins · 2017 · Scientific Reports
  43. Recent Status and Advancements in the Development of Antifungal Agents: Highlights on Plant and Marine Based Antifungals
    Pushpam Marie Arockianathan, Monika Mishra, Rituraj Niranjan · 2019 · Current Topics in Medicinal Chemistry
  44. Metabonomics on Candida albicans indicate the excessive H3K56ac is involved in the antifungal activity of Shikonin
    Zebin Liao, Zhenyu Zhu, Ling Li, Liang Wang, Hui Wang, Yuanying Jiang, Yingying Cao · 2019 · Emerging Microbes & Infections
  45. Chromatin Structure and Drug Resistance in Candida spp.
    Callum J. O’Kane, Rachel Weild, Edel M. Hyland · 2020 · Journal of Fungi
  46. Comparison of Clinical Laboratory Standards Institute (CLSI) Microdilution Method and VITEK 2 Automated Antifungal Susceptibility System for the Determination of Antifungal Susceptibility of Candida Species
    Burcu Dalyan Cılo, Beyza Ener · 2021 · Cureus
  47. Antifungal Macrocycle Antibiotic Amphotericin B—Its Present and Future. Multidisciplinary Perspective for the Use in the Medical Practice
    A. A. Baghirova, Kh. M. Kasumov · 2022 · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry
  48. Combatting Fungal Infections: Advances in Antifungal Polymeric Nanomaterials
    Sebastian Schaefer, Nathaniel Alan Corrigan, Sascha Brunke, Megan Denise Lenardon, Cyrille Andre Boyer · 2024 · Biomacromolecules
  49. Antifungal susceptibility of yeasts isolated from anthropogenic watershed
    Ana Carolina Medeiros Milanezi, João Paulo Duarte Witusk, Sueli Teresinha Van Der Sand · 2018 · Anais da Academia Brasileira de Ciências
  50. Comparison of mortality between echinocandins and polyenes for an initial treatment of candidemia: A systematic review and meta-analysis
    Hideo Kato, Mao Hagihara, Yuichi Shibata, Nobuhiro Asai, Yuka Yamagishi, Takuya Iwamoto, Hiroshige Mikamo · 2021 · Journal of Infection and Chemotherapy
  51. Multi‐Omics Analysis of Experimentally Evolved <i>Candida auris</i> Isolates Reveals Modulation of Sterols, Sphingolipids, and Oxidative Stress in Acquired Amphotericin B Resistance
    Chauhan, Anshu, Carolus, Hans, Sofras, Dimitrios, Kumar, Mohit, Kumar, Praveen, Nair, Remya, Narayanan, Aswathy, Yadav, Kusum, Ali, Basharat, Biriukov, Vladislav et al. · 2025 · Molecular Microbiology
  52. Tetraploidy accelerates adaptation under drug selection in a fungal pathogen
    Ognenka Avramovska, Amanda C Smith, Emily Rego, Meleah A. Hickman · 2022 · Frontiers in Fungal Biology
  53. Plasticity and Stereotypic Rewiring of the Transcriptome Upon Bacterial Evolution of Antibiotic Resistance
    Gábor Grézal, Réka Spohn, Orsolya Méhi, Anett Dunai, Viktória Lázár, Balázs Bálint, István Nagy, Csaba Pál, Balázs Papp · 2023 · Molecular Biology and Evolution
  54. Comparative fitness trade-offs associated with azole resistance in Candida auris clinical isolates
    Sourav Kumar Das, Shreya Singh, Yamini Tawde, Tushar Kanti Dutta, Shivaprakash Mandya Rudramurthy, Harsimran Kaur, Tushar Shaw, Anup Kumar Ghosh · 2024 · Heliyon
  55. What makes Candida auris pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs
    Johanna L. Rhodes, Jonathan L. Jacobs, Emily K. Dennis, Swati R. Manjari, Nilesh K. Banavali, Robert Marlow, Mohammed Anower Rokebul, Sudha Chaturvedi, Vishnu P. Chaturvedi · 2024 · Antimicrobial Agents and Chemotherapy
  56. Well-Tolerated Amphotericin B Derivatives That Effectively Treat Visceral Leishmaniasis
    Christelle Morelle, Angana Mukherjee, Jiabao Zhang, Fereshteh Fani, Anuj Khandelwal, Hélène Gingras, Jocelyn Trottier, Olivier Barbier, Philippe Leprohon, Martin D. Burke et al. · 2021 · ACS Infectious Diseases
  57. Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103
    Phan-Canh, Trinh, Coman, Cristina, Lackner, Michaela, Troppmair, Nina, Müller, Christoph, Cerbu, Diana, Seiser, Saskia, Penninger, Philipp, Tsymala, Irina, Khunweeraphong, Narakorn et al. · 2025 · Nature Microbiology
  58. Identification and Characterization of Key Charged Residues in the Cofilin Protein Involved in Azole Susceptibility, Apoptosis, and Virulence of Aspergillus fumigatus
    Zhongyi Lu, Xiaodong Jia, Yong Chen, Xuelin Han, Fangyan Chen, Shuguang Tian, Xueting Su, Zongwei Li, Jingya Zhao, Xi Zhang et al. · 2018 · Antimicrobial Agents and Chemotherapy
  59. Current Challenges and Updates on the Therapy of Fungal Infections
    Laura Nunes Silva, Thaís Pereira de Mello, Lívia S. Ramos, Marta H. Branquinha, André Luis Souza dos Santos · 2019 · Current Topics in Medicinal Chemistry
  60. Aneuploidy Underlies Brefeldin A‐Induced Antifungal Drug Resistance in Cryptococcus Neoformans
    Zhang, Zhi-hui, Sun, Liu-liu, Fu, Bu-qing, Deng, Jie, Jia, Cheng-lin, Miao, Ming-xing, Yang, Feng, Cao, Yong-bing, Yan, Tian-hua · 2024 · Frontiers in Cellular and Infection Microbiology
  61. Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma auris
    Lauryn Massic, Laura A. Doorley, Sarah J Jones, Irene Richardson, Danielle Denise Siao, Lauren Siao, Philip Dykema, Chi N. Hua, Emily Schneider, Christina A. Cuomo et al. · 2025 · Antimicrobial Agents and Chemotherapy
  62. Mitochondrial Genome Sequences of the Emerging Fungal Pathogen Candida auris
    Elizabeth Misas, Nancy A. Chow, Oscar Mauricio Gómez, José F. Muñoz, Juan Guillermo McEwen, Anastasia P. Litvintseva, Oliver Clay · 2020 · Frontiers in Microbiology
  63. Enhancement of the antibiofilm activity of amphotericin B by polyamine biosynthesis inhibitors
    Zebin Liao, XuanZi ZhangGuan, Zhenyu Zhu, Xiangwen Yao, Yu Yang, Yuanying Jiang, Yingying Cao · 2015 · International Journal of Antimicrobial Agents
  64. The Fungicidal Action of Micafungin is Independent on Both Oxidative Stress Generation and HOG Pathway Signaling in Candida albicans
    Rebeca Alonso‐Monge, José Pedro Guirao-Abad, Ruth Sánchez-Fresneda, Jesús Plá, Genoveva Yagüe, Juan Carlos Argüelles · 2020 · Microorganisms
  65. Superenhanced Removal of Fungal Biofilms by Protease‐Functionalized Amphotericin B Nanocarriers
    Paul J. Weldrick, Matthew James Hardman, Vesselin N. Paunov · 2020 · Advanced NanoBiomed Research
  66. Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in ERG2 as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr
    Mohammad Asadzadeh, Wadha Ahmed Alfouzan, Josie E. Parker, Jacques F. G. M. Meis, Steven L. Kelly, Leena Joseph, Suhail Ahmad · 2023 · Microbiology Spectrum
  67. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery
    Mikhail V. Keniya, Yasmeen N. Ruma, Joel D. A. Tyndall, Brian C. Monk · 2018 · Antimicrobial Agents and Chemotherapy
  68. Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin
    Jin Huei Wong, Mohammad Alfatah, Kiat Whye Kong, Shawn S. Hoon, Wan Lin Yeo, Kuan Chieh Ching, Corinna Jie Hui Goh, Mingzi M. Zhang, Yee Hwee Lim, Fong Tian Wong et al. · 2019 · PLoS ONE
  69. Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects
    László Galgóczy · 2025 · ACS Bio & Med Chem Au
  70. Rimonabant potentiates the antifungal activity of amphotericin B by increasing cellular oxidative stress and cell membrane permeability
    Ming Zhang, Jinghui Lu, Ximeng Duan, Jinyao Chen, Xueyang Jin, Zhao‐Min Lin, Yingxin Pang, Xuexiang Wang, Hong‐Xiang Lou, Wenqiang Chang · 2021 · FEMS Yeast Research
  71. Molecular Mechanisms of Resistance to Antifungals in Candida albicans
    Estela Ruiz‐Baca, Rosa Isela Arredondo-Sánchez, Karina Corral-Pérez, Angélica López-Rodríguez, Iván Meneses‐Morales, Víctor M. Ayala‐García, Ana Lilia Martínez-Rocha · 2021 · Infectious diseases
  72. Interdisciplinary approaches for the discovery of novel antifungals
    Bonnie Yiu, Nicole Robbins, Leah E. Cowen · 2024 · Trends in Molecular Medicine
  73. Transcriptional response of Fusarium oxysporum and Neocosmospora solani challenged with amphotericin B or posaconazole
    Adriana C. Castillo-Castañeda, Silvia J. Cañas-Duarte, Marcela Guevara‐Suarez, Josep Guarro, Silvia Restrepo, Adriana Marcela Celis Ramírez · 2020 · Microbiology
  74. The antiproliferative peptide Ctn[15‐34] is active against multidrug‐resistant yeastsCandida albicansandCryptococcus neoformans
    Francisca Lidiane Linhares de Aguiar, Carolina Sidrim de Paula Cavalcante, Raquel Oliveira dos Santos Fontenelle, Cláudio Borges Falcão, David Andreu, Gandhi Rádis‐Baptista · 2019 · Journal of Applied Microbiology
  75. Candida metrosideri pro tempore sp. nov. and Candida ohialehuae pro tempore sp. nov., two antifungal-resistant yeasts associated with Metrosideros polymorpha flowers in Hawaii
    Joon Klaps, Clara de Vega, Carlos M. Herrera, Robert R. Junker, Bart Lievens, Sergio Álvarez‐Pérez · 2020 · PLoS ONE
  76. Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context
    Emily Boakye-Yiadom, Alex Odoom, Abdul-Halim Osman, Onyansaniba Kweku Ntim, Fleischer C. N. Kotey, Bright K. Ocansey, Eric S. Donkor · 2024 · Therapeutic Advances in Infectious Disease
  77. Emerging Role of Sphingolipids in Amphotericin B Drug Resistance
    Kashish Madaan, Vinay Kumar Bari · 2023 · Microbial Drug Resistance
  78. Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis
    Yangyu Lu, Zhiyan Zhou, Longyi Mo, Qiang Guo, Xian Peng, Tao Hu, Xuedong Zhou, Biao Ren, Xin Xu · 2019 · Applied Microbiology and Biotechnology
  79. Localizing Antifungal Drugs to the Correct Organelle Can Markedly Enhance their Efficacy
    Raphael I. Benhamou, Maayan Bibi, Judith G. Berman, Micha Fridman · 2018 · Angewandte Chemie
  80. Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait
    Mohammad Asadzadeh, Suhail Ahmad, Noura Al‐Sweih, Ziauddin Khan · 2017 · PLoS ONE
  81. Toward the rational design of macrolide antibiotics to combat resistance
    Ànna Pavlova, Jerry M. Parks, Adegboyega K. Oyelere, James C. Gumbart · 2017 · Chemical Biology & Drug Design
  82. The hidden threat: Unveiling the rise of antifungal drug resistance
    Renu Chaudhary, Zoozeal Thakur · 2025 · Microbial Pathogenesis
  83. Combating increased antifungal drug resistance in Cryptococcus, what should we do in the future?
    Hengyu Deng, Jialin Song, Yemei Huang, Chen Yang, Xuelei Zang, Yangyu Zhou, Hongli Li, Bin Dai, Xinying Xue · 2023 · Acta Biochimica et Biophysica Sinica
  84. Local delivery polymer provides sustained antifungal activity of amphotericin B with reduced cytotoxicity
    Rebecca M. Haley, Sean T Zuckerman, Catherine A. Gormley, Julius N. Korley, Horst A. von Recum · 2019 · Experimental Biology and Medicine
  85. Autonomously Replicating Linear Plasmids That Facilitate the Analysis of Replication Origin Function in Candida albicans
    Swati Bijlani, Mathuravani A. Thevandavakkam, Hung-Ji Tsai, Judith G. Berman · 2019 · mSphere
  86. Sensitivity of the Candida albicans trehalose-deficient mutants tps1Δ and tps2Δ to amphotericin B and micafungin
    José Pedro Guirao-Abad, Vanessa Pujante, Ruth Sánchez-Fresneda, Genoveva Yagüe, Juan Carlos Argüelles · 2019 · Journal of Medical Microbiology
  87. Amphotericin B stimulates γδ T and NK cells, and enhances protection from Salmonella infection
    Jodi F. Hedges, Angela M. Mitchell, Kerri Jones, Emily M. Kimmel, Andrew G. Ramstead, Deann Teresa Snyder, Mark A. Jutila · 2015 · Innate Immunity
  88. The Fungal Resistome: A Risk and an Opportunity for the Development of Novel Antifungal Therapies
    Jose Antonio Reales‐Calderón, Gloria Molero, Concha Gil, José Luis Martínez · 2016 · Future Medicinal Chemistry
  89. Gladiolin produced by pathogenic Burkholderia synergizes with amphotericin B through membrane lipid rearrangements
    Claudia Simm, Tzong-Hsien Lee, Harshini Weerasinghe, Dean Walsh, Ioanna T. Nakou, Madhu Shankar, Wai Chung Tse, Yu Long Zhang, Rebecca Inman, Roger J. Mulder et al. · 2024 · mBio
  90. Deletion of the fungus specific protein phosphatase Z1 exaggerates the oxidative stress response in Candida albicans
    Krisztina Szabó, Ágnes Jakab, Szilárd Póliska, Katalin Petrényi, Katalin Éva Kovács, Lama Hasan Bou Issa, Tamás Emri, István Pócsi, Viktor Dombrádi · 2019 · BMC Genomics
  91. BSC2 enhances cell resistance to AmB by inhibiting oxidative damage in Saccharomyces cerevisiae
    Yingying Kong, Qiao Wang, Fangqi Cao, Xiaoyu Zhang, Zhijia Fang, Ping Shi, Handong Wang, Yuhu Shen, Zhiwei Huang · 2020 · Free Radical Research
  92. A Novel Role for Histatin 5 in Combination with Zinc to Promote Commensalism in C. albicans Survivor Cells
    Hannah L. Norris, Rohitashw Kumar, Mira Edgerton · 2021 · Pathogens
  93. Amphotericin B: Polyene Resistance Mechanisms
    Matthew William McCarthy, Elizabeth M. O’Shaughnessy, Thomas J. Walsh · 2017 · Springer eBooks
  94. Resistant Traits in Digital Organisms Do Not Revert Preselection Status despite Extended Deselection: Implications to Microbial Antibiotics Resistance
    Clarence F. G. Castillo, Maurice HT Ling · 2014 · BioMed Research International
  95. Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China
    Sufei Tian, Rong Chen, Hailong Li, Yusheng Wu, Na Wu, Chu Yunzhuo, Ning Jiang, Jingping Zhang, Hong Shang · 2024 · Emerging Microbes & Infections
  96. Experimental Evolution of Antifungal Resistance in Cryptococcus neoformans
    Arianne Bermas, Rebecca S. Shapiro, Jennifer Geddes‐McAlister · 2020 · Current Protocols in Microbiology
  97. What ‘Omics can tell us about antifungal adaptation
    Gabriela Fior Ribeiro, Eszter Denes, Helen Heaney, Delma S. Childers · 2021 · FEMS Yeast Research
  98. Peptide-based molecules for the disruption of bacterial Hsp70 chaperones
    Aweon Richards, Tania J. Lupoli · 2023 · Current Opinion in Chemical Biology
  99. Fungal Fighters: A Comprehensive Guide to Antifungal Therapies of the Past, Present, and Future
    Biswambhar Biswas, Anil Thakur · 2024 · Springer eBooks
  100. In vitro activity of SF001: a next-generation polyene versus amphotericin B
    Roya Vahedi‐Shahandashti, Cornelia Lass‐Flörl · 2025 · Antimicrobial Agents and Chemotherapy